1 September 2014
Saving lives, averting costs
An analysis of the financial implications of achieving earlier diagnosis of colorectal, lung and ovarian cancer
Evoke Incisive Health was commissioned by Cancer Research UK to analyse the financial consequences of earlier diagnosis in planning cancer services. Our findings show that there is a clear financial dividend from earlier diagnosis, as well as a compelling case for improving cancer survival.
